Research Feeds

View All
Characterizing the gut microbiota in females with infertility and preliminary results of a water-soluble dietary fiber intervention study A prebiotic dietary pilot intervention restores faecal metabolites and may be neuroprotective in Parkinson’s Disease Diagnosis of the menopause: NICE guidance and quality standards Causes of Death in End-Stage Kidney Disease: Comparison Between the United States Renal Data System and a Large Integrated Health Care System Factors affecting the absorption and excretion of lead in the rat Factors associated with age at menarche, menstrual knowledge, and hygiene practices among schoolgirls in Sharjah, UAE Cadmium transport in blood serum The non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic Structured Exercise Benefits in Euthyroid Graves’ Disease: Improved Capacity, Fatigue, and Relapse Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease A Pilot Microbiota Study in Parkinson’s Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models Dysbiosis of the Saliva Microbiome in Patients With Polycystic Ovary Syndrome Integrated Microbiome and Host Transcriptome Profiles Link Parkinson’s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain Gut microbiota modulation: a narrative review on a novel strategy for prevention and alleviation of ovarian aging Long-term postmenopausal hormone therapy and endometrial cancer

Copper in infectious disease: Using both sides of the penny Original paper

Researched by:

  • Divine Aleru ID
    Divine Aleru

    User avatarI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

    Read More

December 15, 2025

  • Autoimmune Diseases
    Autoimmune Diseases

    Autoimmune disease is when the immune system mistakenly attacks the body's tissues, often linked to imbalances in the microbiome, which can disrupt immune regulation and contribute to disease development.

Researched by:

  • Divine Aleru ID
    Divine Aleru

    User avatarI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

    Read More

Last Updated: 2025-12-15

Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.

Divine Aleru

I am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

What was studied?

This study explores the dual roles of copper in infectious diseases, highlighting its essential function in both host immune defense and pathogen survival. Copper acts as a toxic substance to pathogens but is also a vital micronutrient necessary for cellular processes, including redox reactions and electron transfer. The research delves into how pathogens utilize copper to thrive within the host while also examining the ways in which the host manipulates copper to combat infections. The study provides a comprehensive understanding of copper’s multifaceted role at the host-pathogen interface.

Who was studied?

The research focuses on the interaction between various pathogens, including bacteria, fungi, and viruses, and the host immune system. It emphasizes how copper is both a weapon for the host and a challenge for pathogens. The study examines how different pathogens, particularly bacterial pathogens, adapt to the toxic effects of copper through mechanisms like copper export and sequestration, enabling them to survive inside host cells. It also investigates the host’s strategies for manipulating copper levels to either enhance its toxic effects against pathogens or limit microbial access to copper to prevent infection.

Most important findings

The study reveals that copper’s role in infection is complex and dual-faceted. On one hand, copper is essential for the host’s immune system, enabling the activation of copper-dependent enzymes that defend against pathogens and regulate oxidative stress. On the other hand, pathogens have developed various mechanisms to counteract copper toxicity, such as copper export systems and the production of metal-binding proteins. These adaptive strategies allow pathogens to survive in environments where copper levels are high, such as within the host during infection. The research highlights how the host also exploits copper’s toxic effects to kill pathogens, particularly through the actions of immune cells like macrophages. Moreover, the study suggests that the manipulation of copper levels, either by enhancing its toxic effects on pathogens or limiting its availability, could provide new therapeutic strategies for managing infections.

Key implications

These findings underscore copper’s essential and paradoxical role in infectious disease. While copper is toxic to many pathogens, its dual role as both a nutrient and a weapon makes it a valuable tool in the host’s immune response. The study’s insights into how pathogens manage copper stress can inform the development of novel therapies, such as copper-based antimicrobial agents, to combat infections. Additionally, understanding how the host manipulates copper to regulate immune responses suggests new approaches for enhancing the immune system during infection. Therapeutic interventions targeting the mechanisms of copper acquisition and resistance in pathogens, as well as strategies to modulate copper levels in the host, could offer new avenues for treating a range of infections.

Copper (Cu)

Copper serves as both a vital nutrient and a potential toxin, with its regulation having profound effects on microbial pathogenesis and immune responses. In the body, copper interacts with pathogens, either supporting essential enzyme functions or hindering microbial growth through its toxicity. The gastrointestinal tract, immune cells, and bloodstream are key sites where copper plays a crucial role in controlling infection and maintaining microbial balance. Understanding copper’s interactions with the microbiome and host defenses allows for targeted clinical strategies.

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.